Centre looks to trim drug input imports from China

This assumes significance in the wake of India’s decision to keep in abeyance a $1.3-billion deal under which Chinese company Shanghai Fosun Pharmaceuticals … we worry it will cast a shadow on business,” said an executive whose company imports …
( read original story …)


Related Post